For Immediate Release, December 6, 2005
Contact: Sung Ho Hahm, Ph.D.
President & CEO
Promogen, Inc.
301-921-6006
shahm@promogen.net

Maryland Technology Development Corporation (TEDCO) has announced its decision to award $75,000 in early-stage funding for Promogen, Inc., to help develop synthetic gene promoter production technology. The funding comes through TEDCO's Maryland Technology Transfer Fund (MTTF). The project will be conducted in collaboration with Professor Dean Mann at the University of Maryland, School of Medicine. TEDCO was created by the Maryland State legislature in 1998. MTTF provides funding for Maryland companies who wish to develop technology-based products and/or services in collaboration with the Universities and/or Federal Laboratories in Maryland.

Maryland Technology Enterprise Institute (MTECH) announced today that Promogen is selected to receive $70,000 of MIPS grant for the project “Construction of Synthetic Gene Promoters” to be conducted in collaboration with Professor Dean Mann at the University of Maryland, School of Medicine, in Baltimore Maryland. The Maryland Industrial Partnerships (MIPS) program accelerates the commercialization of technology in Maryland by jointly funding collaborative R&D projects between companies and University System of Maryland faculty.

Maryland Technology Enterprise Institute (MTECH) announced today that Promogen is selected to receive $70,000 of MIPS Phase II grant for the project "Construction of Synthetic Gene Promoters" to be conducted in collaboration with Professor Dean Mann at the University of Maryland, School of Medicine, in Baltimore Maryland. The MIPS Phase II grant was approved by MTECH based on Promogen's successful completion of Phase I of the project.